CASP3 and exocrine pancreatic carcinoma: Accumulating biochemical results indicated that spiclomazine treatment resulted in cleavage of pro-caspase-3/9 (Figure 4) indicating that spiclomazine induced apoptosis in pancreatic carcinoma cells.